Bioaffinity Technologies WT (BIAFW)

$0.90 +0.04 (4.65%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	N/A
Revenue (ttm)	2.53M
Net Income (ttm)	-7.94M
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	N/A
Debt to Equity Ratio	N/A

Volume	4,000
Avg Vol	7,384
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	9%
Beta	N/A
Analysts	Strong Sell
Price Target	N/A

Company Profile

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indica...

Phone: 210 698 5334

Website: bioaffinitytech.com

Address:

3300 Nacogdoches Road, Suite 216, San Antonio, United States